BioSpace News Archive

Fourth Quarter Net Revenue $2.3 Million, Up 10% Sequentially Over Third Quarter Full Year Revenue $8.6 million, Down 17% Against Prior Year

TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today announced that the FDA’s Office of Health Technology 2 (Cardiovascular Devices) has communicated its intent to hold a Circulatory Systems Device

Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing vaccines, today announced that Ryan Spencer , Chief Executive Officer, will present at the H.C. Wainwright Virtual 2021 Global Life Sciences Conference being held March 9-10, 2021 .

Geron Corporation (Nasdaq: GERN) today announced that it will release its fourth quarter and full year 2020 financial results after the market closes on Thursday, March 11, 2021 via press release, which will be available on the Company’s website at www.geron.com/investors .

Recursion, a digital biology company industrializing drug discovery, today announced the appointment of R. Martin Chavez as Chairman of its Board of Directors.

North Shore Medical Labs announced the operation of a drive-thru COVID-19 testing program at Roosevelt Field in Garden City, New York to support efforts to increase access to testing and help slow the spread of the virus.

Fact.MR, a global research & consulting firm, in their latest edition of the report, projected that the tracheostomy tray market will continue to foresee a robust growth, on account of the growing demand for tracheostomy trays in executing tracheostomy procedures in most of the conditions.

According to the data revealed by the Population Reference Bureau, the genarian population across the world is expected to reach 16% from 9% in 2018.

The global anti-obesity prescription drugs market is expected to see promising growth in forthcoming year, as reported by Transparency Market Research.

The demand within the global market for chronic myelogenous leukaemia treatment has been rising on account of advancements in the worldwide healthcare sector.